Latest filing published 23 Jun 2022 for Spectrum Pharmaceuticals INC, €4,651.
Filing timeline
BuySaleInsider track record
Francois Lebel: trading record in brief
This profile gathers the share dealings of Francois Lebel across 2 companies, led by Spectrum Pharmaceuticals Inc and Alaunos Therapeutics, Inc. Between 9 June 2015 and 23 June 2022, the trades on record add up to 35 filings.
On the market, this insider has only sold: 24 sales, €824k in total. Other entries cover 10 share grants and 1 option exercise. So far in 2022, the count stands at no purchases and 8 sales.
On 23 June 2022 came the latest disclosure, an open-market sale for €4,651 in Spectrum Pharmaceuticals Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Francois Lebel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,096 shares@ US$0.8061.2% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-039063:1
- 6,667 shares@ US$0.8391.4% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-039063:2
- 405,040 shares0Common Stock, $0.001 par valueSEC:0001209191-22-039063:0
- 1,367 shares@ US$1.410.5% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-023224:1
- 1,205 shares@ US$1.352.5% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-023224:0
- 25,105 shares@ US$0.7064.3% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-019341:1
- 25,130 shares@ US$0.70527.0% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-019341:0
- 14,708 shares@ US$0.642.2% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-012928:1
- 13,466 shares@ US$0.70313.9% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-012928:0
- 6,000 shares@ US$2.183.3% of flowCommon Stock, $0.001 par valueSEC:0001209191-21-064002:1
- 7,363 shares@ US$2.20323.4% of flowCommon Stock, $0.001 par valueSEC:0001209191-21-064002:0
- 5,000 shares@ US$4.004.9% of flowCommon Stock, $0.001 par valueSEC:0001209191-21-042775:1
- 5,821 shares@ US$4.08633.2% of flowCommon Stock, $0.001 par valueSEC:0001209191-21-042775:0
- 1,125 shares@ US$3.310.9% of flowCommon Stock, $0.001 par valueSEC:0001209191-21-025722:0
- 1,025 shares@ US$3.240.8% of flowCommon Stock, $0.001 par valueSEC:0001209191-21-025722:1
- 22,631 shares@ US$3.6320.2% of flowCommon Stock, $0.001 par valueSEC:0001209191-21-021497:0
- 18,828 shares@ US$3.6917.1% of flowCommon Stock, $0.001 par valueSEC:0001209191-21-021497:1
- 110,309 shares0Common Stock, $0.001 par valueSEC:0001209191-21-013884:0
- 7,025 shares@ US$3.50316.3% of flowCommon Stock, $0.001 par valueSEC:0001209191-20-057520:0
- 5,000 shares@ US$3.5611.7% of flowCommon Stock, $0.001 par valueSEC:0001209191-20-057520:1
- 5,474 shares@ US$3.168.6% of flowCommon Stock, $0.001 par valueSEC:0001209191-20-038544:0
- 4,167 shares@ US$3.356.9% of flowCommon Stock, $0.001 par valueSEC:0001209191-20-038544:1
- 1,228 shares@ US$2.171.4% of flowCommon Stock, $0.001 par valueSEC:0001209191-20-023586:0
- 854 shares@ US$2.181.0% of flowCommon Stock, $0.001 par valueSEC:0001209191-20-023586:1
- 188,285 shares0Common Stock, $0.001 par valueSEC:0001209191-20-018986:0
25 of 35 declarations